The Haystack Project
  • Home
  • Hospital Inpatient Hospital Outpatient Section 340b MACRA/QPP Patient Assistance Programs ICER Medicaid Other Issues
  • Letters Reports
  • News Events
  • Patient Stories
  • Join
  • About Us
  • Contact
  • Members Only
The Haystack Project
  • Home/
  • Issues/
    • Hospital Inpatient
    • Hospital Outpatient
    • Section 340b
    • MACRA/QPP
    • Patient Assistance Programs
    • ICER
    • Medicaid
    • Other Issues
  • Resources/
    • Letters
    • Reports
  • News/
    • News
    • Events
  • Patient Stories/
  • Join/
  • About Us/
  • Contact/
  • Members Only/
Blue-Banner.png
The Haystack Project

Resources

The Haystack Project
  • Home/
  • Issues/
    • Hospital Inpatient
    • Hospital Outpatient
    • Section 340b
    • MACRA/QPP
    • Patient Assistance Programs
    • ICER
    • Medicaid
    • Other Issues
  • Resources/
    • Letters
    • Reports
  • News/
    • News
    • Events
  • Patient Stories/
  • Join/
  • About Us/
  • Contact/
  • Members Only/
August 06, 2017

Comment Letter on Proposed Inpatient Rule from Bellicum Pharmaceuticals→

August 06, 2017/ Saira Sultan

Read the Bellicum Pharmaceuticals comment on the Hospital Inpatient proposed rule.

Read more.

August 06, 2017/ Saira Sultan/ /Source
Comment Letters
Inpatient

Saira Sultan

  • Comment Letter on IPPS from ...
  • Proposed adaptation of the ICER ...

About Us

The Issues

Resources

News & Updates

© 2017 Haystack Project. All Rights Reserved. 

 

Join Us

Contact Us

The Haystack Project brings together Innovators dedicated to researching and developing treatments for extremely rare diseases with Patients suffering from or caring for them.

Our Mission:
Advocate for reimbursement policies that recognize the unique circumstances of extremely rare conditions and treatments and expand incentives critical to ensuring they can reach patients.